These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31185411)

  • 1. 3,4-Dideoxy-3,3,4,4-tetrafluoro- and 4-OH epimeric 3-deoxy-3,3-difluoro-α-GalCer analogues: Synthesis and biological evaluation on human iNKT cells stimulation.
    Golten S; Patinec A; Akoumany K; Rocher J; Graton J; Jacquemin D; Le Questel JY; Tessier A; Lebreton J; Blot V; Pipelier M; Douillard JY; Le Pendu J; Linclau B; Dubreuil D
    Eur J Med Chem; 2019 Sep; 178():195-213. PubMed ID: 31185411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-fluoro- and 3,3-difluoro-3,4-dideoxy-KRN7000 analogues as new potent immunostimulator agents: total synthesis and biological evaluation in human invariant natural killer T cells and mice.
    Hunault J; Diswall M; Frison JC; Blot V; Rocher J; Marionneau-Lambot S; Oullier T; Douillard JY; Guillarme S; Saluzzo C; Dujardin G; Jacquemin D; Graton J; Le Questel JY; Evain M; Lebreton J; Dubreuil D; Le Pendu J; Pipelier M
    J Med Chem; 2012 Feb; 55(3):1227-41. PubMed ID: 22243602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactosylsphingamides: new α-GalCer analogues to probe the F'-pocket of CD1d.
    Guillaume J; Wang J; Janssens J; Remesh SG; Risseeuw MDP; Decruy T; Froeyen M; Elewaut D; Zajonc DM; Calenbergh SV
    Sci Rep; 2017 Jun; 7(1):4276. PubMed ID: 28655912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amide analogues of CD1d agonists modulate iNKT-cell-mediated cytokine production.
    Wojno J; Jukes JP; Ghadbane H; Shepherd D; Besra GS; Cerundolo V; Cox LR
    ACS Chem Biol; 2012 May; 7(5):847-55. PubMed ID: 22324848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and functional activity of labeled CD1d glycolipid agonists.
    Jervis PJ; Polzella P; Wojno J; Jukes JP; Ghadbane H; Garcia Diaz YR; Besra GS; Cerundolo V; Cox LR
    Bioconjug Chem; 2013 Apr; 24(4):586-94. PubMed ID: 23458425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New CD1d agonists: synthesis and biological activity of 6″-triazole-substituted α-galactosyl ceramides.
    Jervis PJ; Graham LM; Foster EL; Cox LR; Porcelli SA; Besra GS
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4348-52. PubMed ID: 22652050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of C-5″ and C-6″-modified α-GalCer analogues as iNKT-cell agonists.
    Guillaume J; Pauwels N; Aspeslagh S; Zajonc DM; Elewaut D; Van Calenbergh S
    Bioorg Med Chem; 2015 Jul; 23(13):3175-82. PubMed ID: 26003341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of a 2"-deoxy-β-GalCer.
    Thakur MS; Khurana A; Kronenberg M; Howell AR
    Molecules; 2014 Jul; 19(7):10090-102. PubMed ID: 25014535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis for recognition of CD1d/α-galactosylceramide by a human non-Vα24 T cell receptor.
    López-Sagaseta J; Kung JE; Savage PB; Gumperz J; Adams EJ
    PLoS Biol; 2012; 10(10):e1001412. PubMed ID: 23109910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photo effect on the CD1d-binding ability of azobenzene-attached analogues of α-GalCer.
    Kanamori T; Numata T; Kuwabara S; Ishii Y; Watarai H; Yuasa H
    Bioorg Med Chem Lett; 2020 Mar; 30(5):126960. PubMed ID: 31982233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activities of amino acids functionalized α-GalCer analogues.
    Ma W; Bi J; Zhao C; Zhang Z; Liu T; Zhang G
    Bioorg Med Chem; 2020 Jan; 28(1):115141. PubMed ID: 31786009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards multivalent CD1d ligands: synthesis and biological activity of homodimeric α-galactosyl ceramide analogues.
    Jervis PJ; Moulis M; Jukes JP; Ghadbane H; Cox LR; Cerundolo V; Besra GS
    Carbohydr Res; 2012 Jul; 356(9-10):152-62. PubMed ID: 22445102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d.
    Clark K; Yau J; Bloom A; Wang J; Venzon DJ; Suzuki M; Pasquet L; Compton BJ; Cardell SL; Porcelli SA; Painter GF; Zajonc DM; Berzofsky JA; Terabe M
    Front Immunol; 2019; 10():2355. PubMed ID: 31649670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and Discovery of Covalent α-GalCer Derivatives as Potent CD1d Ligands.
    Kishi J; Inuki S; Kashiwabara E; Suzuki T; Dohmae N; Fujimoto Y
    ACS Chem Biol; 2020 Feb; 15(2):353-359. PubMed ID: 31939653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of aromatic group on 4'-OH of α-GalCer manipulated NKT cell cytokine production.
    Zhang W; Xia C; Nadas J; Chen W; Gu L; Wang PG
    Bioorg Med Chem; 2011 Apr; 19(8):2767-76. PubMed ID: 21439833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d molecules.
    Denkberg G; Stronge VS; Zahavi E; Pittoni P; Oren R; Shepherd D; Salio M; McCarthy C; Illarionov PA; van der Merwe A; Besra GS; Dellabona P; Casorati G; Cerundolo V; Reiter Y
    Eur J Immunol; 2008 Mar; 38(3):829-40. PubMed ID: 18253930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of ester and ether analogues of alpha-galactosylceramide (KRN7000).
    Shiozaki M; Tashiro T; Koshino H; Nakagawa R; Inoue S; Shigeura T; Watarai H; Taniguchi M; Mori K
    Carbohydr Res; 2010 Aug; 345(12):1663-84. PubMed ID: 20591421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
    Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
    J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociated expression of natural killer 1.1 and T-cell receptor by invariant natural killer T cells after interleukin-12 receptor and T-cell receptor signalling.
    Emoto M; Shimizu T; Koike H; Yoshizawa I; Hurwitz R; Kaufmann SH; Emoto Y
    Immunology; 2010 Jan; 129(1):62-74. PubMed ID: 20028429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.